Kong YY and Penninger JM |
Molecular control of bone remodeling and osteoporosis. |
2000 |
Exp. Gerontol. |
pmid:11121682
|
Shalhoub V et al. |
Characterization of osteoclast precursors in human blood. |
2000 |
Br. J. Haematol. |
pmid:11122091
|
|
Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. |
2000 |
J. Bone Miner. Res. |
pmid:11127193
|
Wan M et al. |
Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression. |
2001 |
J. Biol. Chem. |
pmid:11139569
|
Browner WS et al. |
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. |
2001 |
J. Clin. Endocrinol. Metab. |
pmid:11158021
|
Yun TJ et al. |
Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. |
2001 |
J. Immunol. |
pmid:11160187
|
Hofbauer LC et al. |
Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11162519
|
Brändström H et al. |
Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11162596
|
Wuyts W et al. |
Evaluation of the role of RANK and OPG genes in Paget's disease of bone. |
2001 |
Bone |
pmid:11165949
|
Takemura M et al. |
Relationship between osteoprotegerin/osteoclastogenesis inhibitory factor concentration in synovial fluid and disease severity in individuals with osteoarthritis of the knee. |
2001 |
Metab. Clin. Exp. |
pmid:11172466
|
Gravallese EM et al. |
The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption. |
2001 |
Arthritis Res. |
pmid:11178122
|
Makiishi-Shimobayashi C et al. |
Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11181055
|
O'Brien EA et al. |
Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. |
2001 |
Bone |
pmid:11182380
|
Bénard J |
[From metastatic osteolysis a painful message: beginning to understand with osteoprotegerin? |
2000 |
Bull Cancer |
pmid:11184451
|
Clohisy DR et al. |
Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice. |
2000 |
J. Orthop. Res. |
pmid:11192258
|
Aubin JE and Bonnelye E |
Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. |
2000 |
Osteoporos Int |
pmid:11193242
|
Wise GE et al. |
Osteoprotegerin and osteoclast differentiation factor in tooth eruption. |
2000 |
J. Dent. Res. |
pmid:11201042
|
Bekker PJ et al. |
The effect of a single dose of osteoprotegerin in postmenopausal women. |
2001 |
J. Bone Miner. Res. |
pmid:11204435
|
Kikuchi T et al. |
Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. |
2001 |
J. Immunol. |
pmid:11207318
|
Kotake S et al. |
[Molecular mechanism of bone metabolism]. |
2000 |
Nippon Naika Gakkai Zasshi |
pmid:11215116
|